Document Detail

Should we induce ketosis in super-refractory status epilepticus?
MedLine Citation:
PMID:  24453081     Owner:  NLM     Status:  Publisher    
Persistent or re-emergent status epilepticus occurs in as many as 20% of patients treated with conventional pharmacotherapy for refractory status epilepticus.(1) The prognosis associated with this "malignant" or "super-refractory" status epilepticus (SRSE) is not universally poor, making therapeutic efforts worthwhile in some cases. Unfortunately, the literature is dominated by anecdotal reports of last-resort therapies that offer little evidence to guide treatment.(2.)
Michael Gruenthal
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-1-22
Journal Detail:
Title:  Neurology     Volume:  -     ISSN:  1526-632X     ISO Abbreviation:  Neurology     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2014-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  APOE {varepsilon}4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory.
Next Document:  Abnormal metabolic network activity in REM sleep behavior disorder.